As complied by Forbe's HealthDay, half of the top ten health news of 2006 feature issues of interest to cancer patients and the cancer community in regard to cancer research, treatment and prevention. The top health story involves the concern over cost of medical care among those with health insurance and the continually growing numbers of uninsured. A recent study shows that one in six, or 50 million people, are struggling to afford medical treatment as they now spend more than ten percent of their income on medical expenses.

After much controversy regarding ethics and morality, this year saw the approval of the first cervical cancer vaccine. The federal government recommends that girls as young as nine-years-old be given the vaccine. The Federal Drug Administration (FDA) re-approved the use of silicone breast implants. Although banned in 1992 because of concerns that silicone leakage might be linked to cancer, silicone implants were still offered to women undergoing breast reconstruction after breast cancer surgery. Supposedly the implants are now safe for all women. Some consumer advocacy groups still strongly disapprove of the FDA decision.

Another controversial issue being debated based on ethics and morality is stem cell research. According to Forbes, the majority of Americans are in favor of stem cell research and the promise it holds in the cure of cancer, heart disease, diabetes, Parkinson's disease, and many other diseases.

Lastly, scandals swept throught the research community as fake research and researchers were exposed, as was conflict of interest over questionable financial ties in the research community.

Other health news stories that made Forbe's HealthDay top ten list included: Tainted-Food Scares Rattle Public; Drug-Eluting Stents May Stay; 'Morning-After' Pill Goes OTC; Antidepressants' Link to Suicide Debated; and More Progress Against Alzheimer's Disease. You can read the Forbe's top ten list in its entirety here.